{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:02:46Z","timestamp":1792267366745,"version":"4.4.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T00:00:00Z","timestamp":1634947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR000448"],"award-info":[{"award-number":["UL1 TR000448"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010390","name":"Saint Louis University","doi-asserted-by":"publisher","award":["S10OD025246"],"award-info":[{"award-number":["S10OD025246"]}],"id":[{"id":"10.13039\/100010390","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA091842"],"award-info":[{"award-number":["P30 CA091842"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P41 GM103422"],"award-info":[{"award-number":["P41 GM103422"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10OD025246"],"award-info":[{"award-number":["S10OD025246"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIDDK-R01DK103746"],"award-info":[{"award-number":["NIDDK-R01DK103746"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007930","name":"Institute of Clinical and Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007930","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.molmet.2021.101364","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T20:01:32Z","timestamp":1635451292000},"page":"101364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Pleiotropic actions of IP6K1 mediate hepatic metabolic dysfunction to promote nonalcoholic fatty liver disease and steatohepatitis"],"prefix":"10.1016","volume":"54","author":[{"given":"Sandip","family":"Mukherjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molee","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Ulmasov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"McCommis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliwaza Naomi","family":"Msengi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Haubner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Pike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarbani","family":"Ghoshal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent A.","family":"Neuschwander-Tetri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0100-6530","authenticated-orcid":false,"given":"Anutosh","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.molmet.2021.101364_bib1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1124\/mol.109.055897","article-title":"Diphosphoinositol polyphosphates: metabolic messengers?","volume":"76","author":"Shears","year":"2009","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.molmet.2021.101364_bib2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/978-94-007-3015-1_14","article-title":"Cell signalling by inositol pyrophosphates","volume":"59","author":"Saiardi","year":"2012","journal-title":"Subcellular Biochemistry"},{"issue":"2","key":"10.1016\/j.molmet.2021.101364_bib3","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/brv.12392","article-title":"The inositol pyrophosphate pathway in health and diseases","volume":"93","author":"Chakraborty","year":"2018","journal-title":"Biological Reviews of the Cambridge Philosophical Society"},{"issue":"1","key":"10.1016\/j.molmet.2021.101364_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s41745-016-0011-3","article-title":"Inositol pyrophosphates: energetic, omnipresent and versatile signalling molecules","volume":"97","author":"Shah","year":"2017","journal-title":"Journal of the Indian Institute of Science"},{"issue":"1","key":"10.1016\/j.molmet.2021.101364_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/febs.12575","article-title":"The enzymes of human diphosphoinositol polyphosphate metabolism","volume":"281","author":"Thomas","year":"2014","journal-title":"FEBS Journal"},{"issue":"6","key":"10.1016\/j.molmet.2021.101364_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25061403","article-title":"Targeting the inositol pyrophosphate biosynthetic enzymes in metabolic diseases","volume":"25","author":"Mukherjee","year":"2020","journal-title":"Molecules"},{"issue":"5854","key":"10.1016\/j.molmet.2021.101364_bib7","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1126\/science.1146824","article-title":"Requirement of inositol pyrophosphates for full exocytotic capacity in pancreatic beta cells","volume":"318","author":"Illies","year":"2007","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.molmet.2021.101364_bib8","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.cell.2010.11.032","article-title":"Inositol pyrophosphates inhibit Akt signaling, thereby regulating insulin sensitivity and weight gain","volume":"143","author":"Chakraborty","year":"2010","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.molmet.2021.101364_bib9","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1172\/JCI85510","article-title":"Adipocyte-specific deletion of Ip6k1 reduces diet-induced obesity by enhancing AMPK-mediated thermogenesis","volume":"126","author":"Zhu","year":"2016","journal-title":"Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/j.molmet.2021.101364_bib10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.molmet.2016.11.010","article-title":"Global IP6K1 deletion enhances temperature modulated energy expenditure which reduces carbohydrate and fat induced weight gain","volume":"6","author":"Zhu","year":"2017","journal-title":"Molecular Metabolism"},{"issue":"7","key":"10.1016\/j.molmet.2021.101364_bib11","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nature Medicine"},{"key":"10.1016\/j.molmet.2021.101364_bib12","doi-asserted-by":"crossref","first-page":"15080","DOI":"10.1038\/nrdp.2015.80","article-title":"Nonalcoholic fatty liver disease","volume":"1","author":"Brunt","year":"2015","journal-title":"Nature reviews Disease primers"},{"issue":"7","key":"10.1016\/j.molmet.2021.101364_bib13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"issue":"4","key":"10.1016\/j.molmet.2021.101364_bib14","doi-asserted-by":"crossref","first-page":"e00112","DOI":"10.1002\/edm2.112","article-title":"The metabolic basis of nonalcoholic steatohepatitis","volume":"3","author":"Chakravarthy","year":"2020","journal-title":"Endocrinol Diabetes Metab"},{"issue":"2","key":"10.1016\/j.molmet.2021.101364_bib15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cmet.2007.12.009","article-title":"Selective versus total insulin resistance: a pathogenic paradox","volume":"7","author":"Brown","year":"2008","journal-title":"Cell Metabolism"},{"issue":"5","key":"10.1016\/j.molmet.2021.101364_bib16","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2018.01.019","article-title":"Fructose and sugar: a major mediator of non-alcoholic fatty liver disease","volume":"68","author":"Jensen","year":"2018","journal-title":"Journal of Hepatology"},{"issue":"2","key":"10.1016\/j.molmet.2021.101364_bib17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tem.2015.11.008","article-title":"The role of cholesterol in the pathogenesis of NASH","volume":"27","author":"Ioannou","year":"2016","journal-title":"Trends in Endocrinology and Metabolism"},{"issue":"10","key":"10.1016\/j.molmet.2021.101364_bib18","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.molmet.2021.101364_bib19","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1053\/j.gastro.2020.01.051","article-title":"Therapeutic landscape for NAFLD in 2020","volume":"158","author":"Neuschwander-Tetri","year":"2020","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.molmet.2021.101364_bib20","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jhep.2017.10.015","article-title":"Pharmacotherapy for NASH: current and emerging","volume":"68","author":"Konerman","year":"2018","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1016\/j.molmet.2021.101364_bib21","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ccell.2014.09.003","article-title":"Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes","volume":"26","author":"Wolf","year":"2014","journal-title":"Cancer Cell"},{"issue":"496","key":"10.1016\/j.molmet.2021.101364_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat9284","article-title":"Hyaluronan synthase 2-mediated hyaluronan production mediates Notch1 activation and liver fibrosis","volume":"11","author":"Yang","year":"2019","journal-title":"Science Translational Medicine"},{"issue":"4","key":"10.1016\/j.molmet.2021.101364_bib23","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41591-019-0379-5","article-title":"Platelet GPIb\u03b1 is a mediator and potential interventional target for NASH and subsequent liver cancer","volume":"25","author":"Malehmir","year":"2019","journal-title":"Nature Medicine"},{"issue":"11","key":"10.1016\/j.molmet.2021.101364_bib24","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1172\/JCI81993","article-title":"ChREBP regulates fructose-induced glucose production independently of insulin signaling","volume":"126","author":"Kim","year":"2016","journal-title":"Journal of Clinical Investigation"},{"issue":"4","key":"10.1016\/j.molmet.2021.101364_bib25","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.cmet.2015.07.028","article-title":"Loss of mitochondrial pyruvate carrier 2 in the liver leads to defects in gluconeogenesis and compensation via pyruvate-alanine cycling","volume":"22","author":"McCommis","year":"2015","journal-title":"Cell Metabolism"},{"issue":"12","key":"10.1016\/j.molmet.2021.101364_bib26","doi-asserted-by":"crossref","first-page":"e115922","DOI":"10.1371\/journal.pone.0115922","article-title":"Establishment of a general NAFLD scoring system for rodent models and comparison to human liver pathology","volume":"9","author":"Liang","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.molmet.2021.101364_bib27","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/hep4.1298","article-title":"An inhibitor of arginine-glycine-aspartate-binding integrins reverses fibrosis in a mouse model of nonalcoholic steatohepatitis","volume":"3","author":"Ulmasov","year":"2019","journal-title":"Hepatol Commun"},{"issue":"6","key":"10.1016\/j.molmet.2021.101364_bib28","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2019.10.034","article-title":"GPR146 deficiency protects against hypercholesterolemia and atherosclerosis","volume":"179","author":"Yu","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.molmet.2021.101364_bib29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.biocel.2016.06.018","article-title":"Inositol hexakisphosphate kinase-1 interacts with perilipin1 to modulate lipolysis","volume":"78","author":"Ghoshal","year":"2016","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"issue":"5","key":"10.1016\/j.molmet.2021.101364_bib30","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2337\/db10-0452","article-title":"O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver","volume":"60","author":"Guinez","year":"2011","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.molmet.2021.101364_bib31","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.yexcr.2006.03.008","article-title":"Involvement of H- and N-Ras isoforms in transforming growth factor-beta1-induced proliferation and in collagen and fibronectin synthesis","volume":"312","author":"Mart\u00ednez-Salgado","year":"2006","journal-title":"Experimental Cell Research"},{"issue":"10","key":"10.1016\/j.molmet.2021.101364_bib32","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.molmet.2016.08.008","article-title":"TNP [N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl)purine] ameliorates diet induced obesity and insulin resistance via inhibition of the IP6K1 pathway","volume":"5","author":"Ghoshal","year":"2016","journal-title":"Mol Metab"},{"issue":"16","key":"10.1016\/j.molmet.2021.101364_bib33","doi-asserted-by":"crossref","first-page":"10571","DOI":"10.1074\/jbc.M900752200","article-title":"Characterization of a selective inhibitor of inositol hexakisphosphate kinases: use in defining biological roles and metabolic relationships of inositol pyrophosphates","volume":"284","author":"Padmanabhan","year":"2009","journal-title":"Journal of Biological Chemistry"},{"issue":"7","key":"10.1016\/j.molmet.2021.101364_bib34","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of fibrosis development in nonalcoholic steatohepatitis","volume":"158","author":"Schwabe","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.molmet.2021.101364_bib35","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1038\/s41598-017-04317-0","article-title":"Focal adhesion kinase regulates hepatic stellate cell activation and liver fibrosis","volume":"7","author":"Zhao","year":"2017","journal-title":"Scientific Reports"},{"issue":"4","key":"10.1016\/j.molmet.2021.101364_bib36","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022293","article-title":"TGF-\u03b21 signaling and tissue fibrosis","volume":"10","author":"Kim","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"2","key":"10.1016\/j.molmet.2021.101364_bib37","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1152\/physrev.00043.2019","article-title":"Role of O-linked N-acetylglucosamine protein modification in cellular (Patho)Physiology","volume":"101","author":"Chatham","year":"2021","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.molmet.2021.101364_bib38","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1146\/annurev-biochem-060608-102511","article-title":"Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease","volume":"80","author":"Hart","year":"2011","journal-title":"Annual Review of Biochemistry"},{"key":"10.1016\/j.molmet.2021.101364_bib39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3389\/fendo.2014.00221","article-title":"A\u00a0bittersweet switch in liver","volume":"5","author":"Zhang","year":"2014","journal-title":"Frontiers in Endocrinology"},{"issue":"7","key":"10.1016\/j.molmet.2021.101364_bib40","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1073\/pnas.0712227105","article-title":"Gene deletion of inositol hexakisphosphate kinase 1 reveals inositol pyrophosphate regulation of insulin secretion, growth, and spermiogenesis","volume":"105","author":"Bhandari","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"issue":"2","key":"10.1016\/j.molmet.2021.101364_bib41","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jbior.2012.03.002","article-title":"How inositol pyrophosphates control cellular phosphate homeostasis?","volume":"52","author":"Saiardi","year":"2012","journal-title":"Adv Biol Regul"},{"issue":"5704","key":"10.1016\/j.molmet.2021.101364_bib42","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1126\/science.1103344","article-title":"Phosphorylation of proteins by inositol pyrophosphates","volume":"306","author":"Saiardi","year":"2004","journal-title":"Science"},{"issue":"19","key":"10.1016\/j.molmet.2021.101364_bib43","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1042\/BCJ20160610","article-title":"Inositol hexakisphosphate kinase 1 (IP6K1) activity is required for cytoplasmic dynein-driven transport","volume":"473","author":"Chanduri","year":"2016","journal-title":"Biochemical Journal"},{"issue":"435","key":"10.1016\/j.molmet.2021.101364_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal4045","article-title":"Inhibition of IP6K1 suppresses neutrophil-mediated pulmonary damage in bacterial pneumonia","volume":"10","author":"Hou","year":"2018","journal-title":"Science Translational Medicine"},{"issue":"2","key":"10.1016\/j.molmet.2021.101364_bib45","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcmgh.2017.05.004","article-title":"Identification of the consistently altered metabolic targets in human hepatocellular carcinoma","volume":"4","author":"Nwosu","year":"2017","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.molmet.2021.101364_bib46","doi-asserted-by":"crossref","first-page":"32072","DOI":"10.1038\/srep32072","article-title":"Inositol hexakisphosphate kinase 3 regulates metabolism and lifespan in mice","volume":"6","author":"Moritoh","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/j.molmet.2021.101364_bib47","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ebiom.2018.04.009","article-title":"Activation of liver AMPK with PF-06409577 corrects NAFLD and lowers cholesterol in rodent and primate preclinical models","volume":"31","author":"Esquejo","year":"2018","journal-title":"EBioMedicine"},{"issue":"37","key":"10.1016\/j.molmet.2021.101364_bib48","doi-asserted-by":"crossref","first-page":"62780","DOI":"10.18632\/oncotarget.19376","article-title":"AMPK: a novel target for treating hepatic fibrosis","volume":"8","author":"Liang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.molmet.2021.101364_bib49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev-pharmtox-010716-104727","article-title":"Emerging pharmacological targets for the treatment of nonalcoholic fatty liver disease, insulin resistance, and type 2 diabetes","volume":"59","author":"Goedeke","year":"2019","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"1","key":"10.1016\/j.molmet.2021.101364_bib50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40259-012-0003-4","article-title":"Targeting focal adhesion kinase in fibrotic diseases","volume":"27","author":"Lagares","year":"2013","journal-title":"BioDrugs"},{"issue":"5","key":"10.1016\/j.molmet.2021.101364_bib51","article-title":"New insights into the biology of protein O-GlcNAcylation: approaches and observations","volume":"1","author":"Mueller","year":"2021","journal-title":"Frontiers in Aging"},{"issue":"8","key":"10.1016\/j.molmet.2021.101364_bib52","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1073\/pnas.1700165114","article-title":"Neuronal migration is mediated by inositol hexakisphosphate kinase 1 via alpha-actinin and focal adhesion kinase","volume":"114","author":"Fu","year":"2017","journal-title":"Proceedings of the National Academy of Sciences of the U S A"},{"issue":"11","key":"10.1016\/j.molmet.2021.101364_bib53","doi-asserted-by":"crossref","first-page":"7097","DOI":"10.1074\/jbc.M114.617779","article-title":"Conditional knock-out reveals a requirement for O-linked N-Acetylglucosaminase (O-GlcNAcase) in metabolic homeostasis","volume":"290","author":"Keembiyehetty","year":"2015","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.molmet.2021.101364_bib54","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1038\/s41467-018-07461-x","article-title":"Adipocyte OGT governs diet-induced hyperphagia and obesity","volume":"9","author":"Li","year":"2018","journal-title":"Nature Communications"},{"issue":"2","key":"10.1016\/j.molmet.2021.101364_bib55","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jhep.2017.03.017","article-title":"O-GlcNAc transferase promotes fatty liver-associated liver cancer through inducing palmitic acid and activating endoplasmic reticulum stress","volume":"67","author":"Xu","year":"2017","journal-title":"Journal of Hepatology"},{"issue":"8","key":"10.1016\/j.molmet.2021.101364_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082165","article-title":"Silibinin ameliorates O-GlcNAcylation and inflammation in a mouse model of nonalcoholic steatohepatitis","volume":"19","author":"Lee","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"issue":"11","key":"10.1016\/j.molmet.2021.101364_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/nu11112702","article-title":"Curcumin ameliorates nonalcoholic fatty liver disease through inhibition of O-GlcNAcylation","volume":"11","author":"Lee","year":"2019","journal-title":"Nutrients"},{"issue":"21","key":"10.1016\/j.molmet.2021.101364_bib58","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.127709","article-title":"O-GlcNAc transferase suppresses necroptosis and liver fibrosis","volume":"4","author":"Zhang","year":"2019","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.molmet.2021.101364_bib59","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1254\/jphs.09236SC","article-title":"Protein O-glycosylation induces collagen expression and contributes to diabetic cardiomyopathy in rat cardiac fibroblasts","volume":"111","author":"Kohda","year":"2009","journal-title":"Journal of Pharmacological Sciences"},{"issue":"6","key":"10.1016\/j.molmet.2021.101364_bib60","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1007\/s10753-013-9662-7","article-title":"Protein O glycosylation regulates activation of hepatic stellate cells","volume":"36","author":"Fan","year":"2013","journal-title":"Inflammation"},{"key":"10.1016\/j.molmet.2021.101364_bib61","doi-asserted-by":"crossref","DOI":"10.1111\/jgh.15690","article-title":"O-GlcNAcylation inhibits hepatic stellate cell activation","author":"Li","year":"2021","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"5","key":"10.1016\/j.molmet.2021.101364_bib62","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jhep.2009.02.019","article-title":"Uncoupling proteins and non-alcoholic fatty liver disease","volume":"50","author":"Cortez-Pinto","year":"2009","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1016\/j.molmet.2021.101364_bib63","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1053\/jhep.2002.32028","article-title":"Obesity-related fatty liver is unchanged in mice deficient for mitochondrial uncoupling protein 2","volume":"35","author":"Baffy","year":"2002","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.molmet.2021.101364_bib64","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2013.10.004","article-title":"Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a liver-targeted mitochondrial uncoupler","volume":"18","author":"Perry","year":"2013","journal-title":"Cell Metabolism"},{"issue":"6057","key":"10.1016\/j.molmet.2021.101364_bib65","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1126\/science.1211908","article-title":"Influence of inositol pyrophosphates on cellular energy dynamics","volume":"334","author":"Szijgyarto","year":"2011","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.molmet.2021.101364_bib66","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.cellsig.2016.04.011","article-title":"Deletion of inositol hexakisphosphate kinase 1 (IP6K1) reduces cell migration and invasion, conferring protection from aerodigestive tract carcinoma in mice","volume":"28","author":"Jadav","year":"2016","journal-title":"Cellular Signalling"},{"key":"10.1016\/j.molmet.2021.101364_bib67","series-title":"Use of protein kinase-focused compound libraries for the discovery of New inositol phosphate kinase inhibitors","author":"Puhl-Rubio","year":"2018"},{"key":"10.1016\/j.molmet.2021.101364_bib68","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.8b01593","article-title":"Inhibition of inositol polyphosphate kinases by quercetin and related flavonoids: a structure-activity analysis","author":"Gu","year":"2019","journal-title":"Journal of Medicinal Chemistry"},{"issue":"2","key":"10.1016\/j.molmet.2021.101364_bib69","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1021\/acsptsci.0c00218","article-title":"Identification of small-molecule inhibitors of human inositol hexakisphosphate kinases by high-throughput screening","volume":"4","author":"Liao","year":"2021","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"1","key":"10.1016\/j.molmet.2021.101364_bib70","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1038\/s41467-021-24934-8","article-title":"The enzymatic activity of inositol hexakisphosphate kinase controls circulating phosphate in mammals","volume":"12","author":"Moritoh","year":"2021","journal-title":"Nature Communications"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877821002118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877821002118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:21:06Z","timestamp":1778851266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877821002118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":70,"alternative-id":["S2212877821002118"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2021.101364","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pleiotropic actions of IP6K1 mediate hepatic metabolic dysfunction to promote nonalcoholic fatty liver disease and steatohepatitis","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2021.101364","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101364"}}